| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5814011 | Neuropharmacology | 2015 | 16 Pages |
Abstract
Targeting 5-HT1A receptors with selective biased agonists exerts distinct effects in the rat model of PD and LID. Preferential activation of 5-HT1A autoreceptors could potentially translate to superior antidyskinetic and l-DOPA dose-sparing effects in PD patients.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
H. Iderberg, A.C. McCreary, M.A. Varney, M.A. Cenci, A. Newman-Tancredi,